Literature DB >> 97711

Acute and chronic effects of lithium chloride on physiological and psychological measures in normals.

I G Karniol, J Dalton, M H Lader.   

Abstract

In the acute experiment six healthy volunteers were given orally two doses of lithium chloride, 16 and 32 mmol, and placebo sodium chloride 32 mmol in a double-blind standardized procedure, with a 1-week interval between treatments. Compared to sodium, lithium produced a decrease in subjective well-being, decrease of skin conductance fluctuations, and increase in plasma calcium concentrations. Dose-related effects were maximal at the first hour after ingestion, decreasing or disappearing at 3--5 h. Most effects did not correlate with plasma or erythrocyte lithium concentrations, but drug effects and feelings of nausea were highly correlated. Accordingly, most acute effects seemed due to peripheral drug effects. In the chronic experiment six healthy volunteers were given orally 16 mmol of lithium chloride or sodium chloride (placebo) twice a day for 1 week in a double-blind standardized procedure with a 2-week interval between treatment weeks. Compared to placebo, lithium produced feelings of subjective impairment, an increase in EEG slow waves and of auditory evoked response variability, a deficit in long-term memory, and an increase in plasma magnesium concentrations. Most lithium effects did not correlate with plasma or erythrocyte lithium concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97711     DOI: 10.1007/bf00426753

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Letter: Cognitive function in patients on lithium therapy.

Authors:  M J Aminoff; J Marshall; E Smith; M Wyke
Journal:  Br J Psychiatry       Date:  1974-07       Impact factor: 9.319

2.  Visual-motor performance during lithium treatment--a preliminary report.

Authors:  R G Demers; G R Heninger
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Jul-Aug

Review 3.  Lithium in psychiatric therapy and prophylaxis.

Authors:  M Schou
Journal:  J Psychiatr Res       Date:  1968-06       Impact factor: 4.791

4.  EEG and neurophysiological studies of lithium in normal volunteers.

Authors:  J G Small; V Milstein; H C Perez; I F Small; D F Moore
Journal:  Biol Psychiatry       Date:  1972-08       Impact factor: 13.382

5.  Salivary secretion and depressive illness: a physiological and psychometric study.

Authors:  P Noble; M Lader
Journal:  Psychol Med       Date:  1971-11       Impact factor: 7.723

6.  Single dose-effect relationships of lithium on the electrical activity of the cerebral cortex and of the heart.

Authors:  C C Pfeiffer; M Singh; L Goldstein
Journal:  J Clin Pharmacol J New Drugs       Date:  1969 Sep-Oct

7.  Biochemical aspects of lithium in affective disorders.

Authors:  S R Platman; R R Fieve
Journal:  Arch Gen Psychiatry       Date:  1968-12

8.  Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values.

Authors:  E P Worrall; J P Moody; G J Naylor
Journal:  Br J Psychiatry       Date:  1975-05       Impact factor: 9.319

9.  Lithium-induced EEG changes: relation to lithium levels in serum and red blood cells.

Authors:  T Zakowska-Dabrowska; J Rybakowski
Journal:  Acta Psychiatr Scand       Date:  1973       Impact factor: 6.392

10.  The clinical laboratory and electroencephalographic effects of lithium.

Authors:  D Mayfield; R G Brown
Journal:  J Psychiatr Res       Date:  1966-12       Impact factor: 4.791

View more
  17 in total

1.  Effect of lithium carbonate on memory processes of bipolar affectively ill patients.

Authors:  V I Reus; S D Targum; H Weingarter; R M Post
Journal:  Psychopharmacology (Berl)       Date:  1979-05-08       Impact factor: 4.530

Review 2.  Management of adverse effects of mood stabilizers.

Authors:  Andrea Murru; Dina Popovic; Isabella Pacchiarotti; Diego Hidalgo; Jordi León-Caballero; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

Review 3.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

4.  Clinical pharmacology of a new antidepressant, Y-8894 in healthy young and elderly volunteers.

Authors:  C Ogura; A Kishimoto; N Kunimoto; F Omura; M Matsubayashi; T Tsutsui; M Shimizu
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

Review 5.  Predicting the emetic liability of novel chemical entities: a comparative study.

Authors:  Nathalie Percie du Sert; Anthony M Holmes; Rob Wallis; Paul Lr Andrews
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats.

Authors:  N J McKay; D Daniels
Journal:  J Neuroendocrinol       Date:  2013-10       Impact factor: 3.627

Review 7.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

Review 8.  Lithium and cognitive enhancement: leave it or take it?

Authors:  Eleftheria Tsaltas; Dimitris Kontis; Vasileios Boulougouris; George N Papadimitriou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-10       Impact factor: 4.530

Review 9.  The effects of lithium on cognition: an updated review.

Authors:  Arlin K Pachet; Amy M Wisniewski
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

10.  Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Authors:  A W Zuardi; I Shirakawa; E Finkelfarb; I G Karniol
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.